Use of amikacin and amoxicillin-clavulanic acid against Mycobacterium tuberculosis.
Tamás
F
F
D000583:Amikacin / Q000494:pharmacology*; D000658:Amoxicillin / Q000008:administration & dosage / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D003470:Culture Media; D004338:Drug Combinations; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000254:growth & development; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000008:administration & dosage / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D003470:Culture Media; D004338:Drug Combinations; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; D000658:Amoxicillin; D000583:Amikacin; D001618:beta-Lactamases